HAYLEY VANDENBERG: Open Payments
NPI 1730602376 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$559 in 18 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $133 · 2025 $559
Food & beverage: $559
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $140 |
| BIOTISSUE HOLDINGS INC. | 1 | $117 |
| Novartis Pharmaceuticals Corporation | 3 | $64 |
| PFIZER INC. | 2 | $52 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| Procept Biorobotics Corporation | 1 | $34 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| Boston Scientific Corporation | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Janssen Biotech, Inc. | 1 | $16 |
Products named: BOTOX, PLUVICTO, XTANDI, AQUABEAM ROBOTIC SYSTEM, LYNPARZA, Xofigo, Nubeqa, AMS 800 Artificial Urinary Sphincter.
Industry payments across CA — which companies pay providers there.
